VAL001
Partner agreement at the top of the wish list for Respiratorius
With positive phase I/IIa data, Respiratorius has been recommended to proceed directly to phase III with the drug candidate VAL001. During the journey...
Respiratorius CEO: "Continuing to reduce the risk in the project"
Partnering work continues for Respiratorius, who recently released their...
Respiratorius half-year summary: positive patent decision and secured financial sustainability
Respiratorius' half-year report for 2024 highlights the positive...
Patent approval for Respiratorius after complicated process
It has been a long and arduous process,...
Respiratorius continues to seek partners with issuance
With promising data behind it, Respiratorius stands on...
Respiratorius CEO on partnership and issue
The company is developing a treatment for diffuse large B-cell lymphoma....
BioStock Investor Pitch: Respiratory
Lund-based Respiratorius continues partnering work ahead of phase III. In...
Respiratorius takes new steps in the partnering work
The in-depth partner discussions have resulted in Respiratorius...
Respiratorius' US patent application is reopened
After initial rejection of Respiratorius' patent application, it has...
In-depth partner discussions for Respiratorius
The Lunda company Respiratorius is in a crucial...
Respiratorius CEO: “Strong faith but patience regarding agreements”
Lund-based Respiratorius continues talks to reach a...
Respiratorius secures additional patents
Respiratorius has secured its second patent for the drug candidate...
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
